I think it is more than the broker report. People are finally waking up to this incredibley promising company. Southern Cross did a similar report on PRR valuing them also about 5 times their current price.
Heres hoping they are correct on both australian biotechs.
- Forums
- ASX - By Stock
- MSB
- the stem cell opportunity
MSB
mesoblast limited
Add to My Watchlist
0.87%
!
$2.32

the stem cell opportunity, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.32 |
Change
0.020(0.87%) |
Mkt cap ! $2.937B |
Open | High | Low | Value | Volume |
$2.29 | $2.34 | $2.27 | $2.577M | 1.118M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 43050 | $2.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 61662 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 42099 | 2.310 |
22 | 64581 | 2.300 |
18 | 143381 | 2.290 |
20 | 166455 | 2.280 |
10 | 52773 | 2.270 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 44811 | 27 |
2.330 | 103111 | 24 |
2.340 | 115943 | 22 |
2.350 | 77548 | 16 |
2.360 | 292538 | 15 |
Last trade - 11.44am 18/09/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |